Vitiligo Lesions Improved after Oral Cyclosporine in a Patient with Vitiligo and Atopic Dermatitis / 대한피부과학회지
Korean Journal of Dermatology
; : 159-162, 2012.
Article
em Ko
| WPRIM
| ID: wpr-165113
Biblioteca responsável:
WPRO
ABSTRACT
Vitiligo is an acquired cutaneous disorder of pigmentation with no definite etiology. Although there are a number of treatment modalities including phototherapy, topical corticosteroids and topical immunomodulators, few studies on the effect of systemic cyclosporine for the treatment of vitiligo have been conducted. We have experienced the improvement of vitiligo lesions after 8 months of systemic administration of cyclosporine (2.5~3.3 mg/kg/day) in a patient with vitiligo and atopic dermatitis. We believe this case report warrants further investigations of cyclosporine for the treatment of vitiligo in terms of mechanisms and clinical outcomes as well.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Fototerapia
/
Vitiligo
/
Pigmentação
/
Ciclosporina
/
Corticosteroides
/
Dermatite Atópica
/
Fatores Imunológicos
Limite:
Humans
Idioma:
Ko
Revista:
Korean Journal of Dermatology
Ano de publicação:
2012
Tipo de documento:
Article